Your browser doesn't support javascript.
loading
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.
Cai, Weijia; Nguyen, Mai Q; Wilski, Nicole A; Purwin, Timothy J; Vernon, Mégane; Tiago, Manoela; Aplin, Andrew E.
Afiliação
  • Cai W; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Nguyen MQ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Wilski NA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Purwin TJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Vernon M; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Tiago M; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Aplin AE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cancer Res ; 82(14): 2625-2639, 2022 07 18.
Article em En | MEDLINE | ID: mdl-35657206
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MAP Quinase Quinase 1 / MAP Quinase Quinase 2 / GTP Fosfo-Hidrolases / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MAP Quinase Quinase 1 / MAP Quinase Quinase 2 / GTP Fosfo-Hidrolases / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article